Literature DB >> 19112102

Adenovirus E1A regulates lung epithelial ICAM-1 expression by interacting with transcriptional regulators at its promoter.

Kiyoshi Morimoto1, John Gosselink, Aileen Kartono, James C Hogg, Shizu Hayashi, Emiko Ogawa.   

Abstract

We focused on the regulation of inflammatory mediator expression by adenovirus E1A in lung epithelial cells and the role of this viral protein in the pathogenesis of chronic obstructive pulmonary disease (COPD). We previously reported that E1A, a well-known regulator of host genes, increased ICAM-1 expression in human bronchial epithelial (HBE) and A549 cells in response to LPS stimulation. In this report, we clarified the mechanism of this regulation. We found NF-kappaB translocation to the nucleus after LPS stimulation in both E1A-positive and -negative HBE cells. ICAM-1 promoter reporter constructs revealed that a mutation in the proximal NF-kappaB binding site completely inhibited increased transcription, whereas the mutation in a distal site did not. We analyzed the participation of E1A in transcriptional complex formation at this promoter using chromatin immunoprecipitation. In E1A-positive HBE and A549 cells, LPS stimulation increased ICAM-1 promoter immunoprecipitation by NF-kappaB p65 and p300 but not activator protein-1 antibodies with a concomitant increase by the E1A antibody. No increase was found in E1A-negative cells except in HBE cells with p65 antibody. The association of E1A with the increased promoter immunoprecipitation with p300 was also observed after TNF-alpha stimulation of A549 cells. These results suggest that adenovirus E1A regulates the ICAM-1 promoter through its proximal NF-kappaB binding site, most likely by interacting with the transcriptional complex that forms at this site. E1A regulation of the LPS response may play a role in acute exacerbations as a consequence of bacterial infections in COPD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19112102     DOI: 10.1152/ajplung.90331.2008

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  6 in total

1.  The lung tissue microbiome in chronic obstructive pulmonary disease.

Authors:  Marc A Sze; Pedro A Dimitriu; Shizu Hayashi; W Mark Elliott; John E McDonough; John V Gosselink; Joel Cooper; Don D Sin; William W Mohn; James C Hogg
Journal:  Am J Respir Crit Care Med       Date:  2012-03-15       Impact factor: 21.405

2.  Armoring CRAds with p21/Waf-1 shRNAs: the next generation of oncolytic adenoviruses.

Authors:  N Höti; W H Chowdhury; S Mustafa; J Ribas; M Castanares; T Johnson; M Liu; S E Lupold; R Rodriguez
Journal:  Cancer Gene Ther       Date:  2010-05-07       Impact factor: 5.987

3.  Role of genetic susceptibility to latent adenoviral infection and decreased lung function.

Authors:  Ikuma Kasuga; James C Hogg; Peter D Paré; Shizu Hayashi; Edward G Sedgwick; Jian Ruan; Alison M Wallace; Jian-Qing He; Xiaozhu Zhang; Andrew J Sandford
Journal:  Respir Med       Date:  2009-06-06       Impact factor: 3.415

Review 4.  Respiratory Viral Infections in Exacerbation of Chronic Airway Inflammatory Diseases: Novel Mechanisms and Insights From the Upper Airway Epithelium.

Authors:  Kai Sen Tan; Rachel Liyu Lim; Jing Liu; Hsiao Hui Ong; Vivian Jiayi Tan; Hui Fang Lim; Kian Fan Chung; Ian M Adcock; Vincent T Chow; De Yun Wang
Journal:  Front Cell Dev Biol       Date:  2020-02-25

5.  Critical role of RIG-I-like receptors in inflammation in chronic obstructive pulmonary disease.

Authors:  Qiurui Zhang; Huanying Wan; Shaoguang Huang; Yan Zhang; Yanchun Wang; Xiaokui Guo; Ping He; Min Zhou
Journal:  Clin Respir J       Date:  2014-09-03       Impact factor: 2.570

6.  Bacterial and viral infections and related inflammatory responses in chronic obstructive pulmonary disease.

Authors:  Silvestro Ennio D'Anna; Mauro Maniscalco; Francesco Cappello; Mauro Carone; Andrea Motta; Bruno Balbi; Fabio L M Ricciardolo; Gaetano Caramori; Antonino Di Stefano
Journal:  Ann Med       Date:  2021-12       Impact factor: 4.709

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.